Citius Pharmaceuticals- Warrants(02/08/2022) Common Stock

As of the most recent data (June 2026), CTXRW shows a common stock of $27K. That compares with $14K in the prior-year period — up 89.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTXRW's common stock is now $27K (was $14K) — a 89.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Pharmaceuticals- Warrants(02/08/2022) is outperforming or lagging.

Tracking CTXRW's common stock over time shows whether Citius Pharmaceuticals- Warrants(02/08/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $27K That compares with $14K in the prior-year period — up 89.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Citius Pharmaceuticals- Warrants(02/08/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $27K) with ownership activity and broader fundamentals.

Citius Pharmaceuticals- Warrants(02/08/2022)'s common stock is $27K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.